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Autoantibodies in Scurfy Mice and IPEX Patients
Recognize Keratin 14
Eva N. Huter1, Kannan Natarajan1, Troy R. Torgerson2, Deborah D. Glass1 and Ethan M. Shevach1
Scurfy mice have a deletion in the Foxp3 gene, resulting in a failure to generate Foxp3þ regulatory T cells, and
they subsequently develop severe CD4þ T-cell-mediated autoimmune inflammation. Multiple organs are involved,
but the skin is one of the main organs affected. During the course of disease, Scurfy mice develop auto-
antibodies; however, the targeted antigens are unknown. In this study, we show that Scurfy mice develop
autoantibodies directed against skin antigens. Using western blot analysis, we found that Scurfy serum reacted
with proteins in total skin lysate, as well as in a keratinocyte lysate. Most of the Scurfy sera tested identified
a major band at 50 kDa. Transfer of Scurfy CD4þ T cells into nu/nu mice yielded autoantibodies with similar
reactivity. Further analysis using 2D western blots, followed by peptide mass fingerprinting, identified several
keratins as targets. To confirm this observation, we chose one of the identified targets, keratin 14, and prepared
recombinant proteins encompassing the N-terminal, middle, and C-terminal portions of the keratin 14 protein.
Scurfy serum predominantly recognized the C-terminal fragment. Sera from patients with immunodysregu-
lation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, the human disease resulting from FOXP3
mutations, also recognized skin antigens, including keratin 14. Thus, the results of our study indicate that
autoantibodies in Scurfy mice and patients with IPEX target keratins.
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INTRODUCTION
Regulatory T cells (Treg) maintain peripheral tolerance by
suppressing autoreactive T cells (Maloy and Powrie, 2001;
Sakaguchi et al., 2001; Shevach, 2002). The transcription
factor Foxp3 is important for the development and function of
naturally occurring Treg cells (Fontenot et al., 2003; Gavin
et al., 2007). Scurfy mice lack functional Treg because of
disruption of the Foxp3 gene by a 2 bp insertion and develop
a lymphoproliferative disease with multiorgan inflammation
(Godfrey et al., 1991a, b). Autoreactive CD4þ effector T cells
infiltrate tissues, secrete cytokines, recruit other inflammatory
cells, and ultimately lead to the destructive pathology present
in liver, lung, and skin. B cells are also activated in the Scurfy
mouse and high antibody titers are present in the serum
(Godfrey et al., 1991b). However, none of the antigenic
targets recognized by autoreactive T cells and autoantibodies
have thus far been identified.
We asked if an autoimmune response directed against skin
antigens exists in Scurfy mice. We screened Scurfy sera for
reactivity to skin proteins and identified several keratins as
antigenic targets. We showed by adoptive transfer experi-
ments involving nu/nu mice that Scurfy CD4þ T cells
provided T cell help to autoreactive B cells present in the
normal B cell pool, leading to the generation of autoanti-
bodies similar to the ones present in Scurfy serum. For one of
the target antigens, keratin 14, we localized the predominant
epitope to the C-terminal part of the protein.
Patients with the immunodysregulation, polyendocrino-
pathy, enteropathy, X-linked syndrome (IPEX) (Wildin and
Freitas, 2005; Ochs et al., 2007), which resembles the disease
in Scurfy mice (Bennett et al., 2001; Wildin et al., 2001)
and is also caused by mutations in FOXP3 gene (Bennett
et al., 2001), often present with severe skin disease (Wildin
et al., 2002; Gambineri et al., 2008; Halabi-Tawil et al.,
2009). We tested sera from IPEX patients with and without
skin disease using western blot for their reactivity to skin
antigens and identified strong reactivity in one of the patients
with eczema. Taken together, these data identify keratins as
antigenic targets in autoimmune disease and should facilitate
the investigation of the specificity of autoreactive T cells in
autoimmune skin diseases.
RESULTS
Scurfy mice develop severe skin inflammation
Between days 10 and 14, Scurfy mice develop visible skin
disease. At day 21, large inflammatory infiltrates in the dermis
lead to severe thickening of the ear and the dermoepidermal
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junction is effaced (Figure 1a). Inflammatory cells also
infiltrate the epidermis and in some areas completely replace
it (Figure 1a, lower panel). We stained skin sections from
RAG/mice with Scurfy or wild-type (WT) littermate sera by
immunohistochemistry. Scurfy serum recognized mainly
epidermal structures (Figure 1b). Some of the sera from
individual Scurfy mice reacted predominantly with the basal
layer of keratinocytes, whereas other sera reacted with the
upper layers or with the entire epidermis. No staining was
observed with control sera (Figure 1b).
Scurfy serum contains autoantibodies against skin antigens
We screened the reactivity of Scurfy sera and sera from
littermate controls with total skin lysates using western blot
analysis. To exclude the possibility that protein–antibody
complexes might already be present in skin lysates, we
prepared lysates from RAG/ skin for all experiments. Scurfy
sera recognized proteins in the skin lysate, whereas
control sera did not (Figure 2a). We then isolated keratino-
cytes from newborn mouse skin as previously described
(Lichti et al., 2008) and prepared keratinocyte lysates for
western blot analysis. In contrast to control sera, Scurfy
sera recognized several proteins in the keratinocyte lysate
(Figure 2b).
Autoantibodies in Scurfy sera target keratinocytes
To rule out a possible abnormality in scurfy skin that
predisposes to autoantibody production, we determined if
Scurfy B cells also mounted antibody responses to keratino-
cyte antigens expressed in the skin of mice not harboring the
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Figure 1. Scurfy mice develop severe skin inflammation with destruction of
the dermoepidermal junction. (a) Ear sections from Scurfy mice and WT
littermate controls were taken on day 21. Hematoxylin and eosin (H&E)
staining; bar¼ 200 mm. The lower panel shows the dermoepidermal junction
from a Scurfy mouse ear at higher magnification. H&E staining; bar¼ 50 mm,
black arrows indicate the dermoepidermal junction. (b) Frozen sections of
skin from RAG/ mice were stained with either Scurfy or WT littermate
control serum as primary antibody, followed by anti-mouse IgG Alexa Fluor
488, DAPI counterstain in blue. Bar¼ 50mm.
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Figure 2. Scurfy autoantibodies recognize target antigens in keratinocytes.
(a) Skin lysate from RAG/ mice was separated on SDS-PAGE, followed
by western blot. Single strips were cut and then stained individually with
either Scurfy or WT littermate control sera as primary antibody, followed by
anti-mouse-horseradish peroxidase (HRP). Each lane represents staining with
serum of an individual mouse. One representative experiment of at least three
with similar results is shown. (b) Lysates from freshly isolated keratinocytes
were separated on SDS-PAGE, followed by western blot using either Scurfy or
WT control sera as described in (a). One representative experiment of at least
five with similar results is shown.
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Scurfy mutation. Total cells from lymph nodes and spleens of
Scurfy mice are transferred into RAG/ recipients (Huter
et al., 2008). All recipient mice developed skin pathology
very similar to that seen in Scurfy mice (data not shown). The
sera of the recipients obtained 4 weeks after transfer reacted
with the same pattern of keratinocyte antigens as those
recognized by Scurfy sera (Figure 3a).
In this model, the Scurfy B cells received T cell help from
Scurfy T cells transferred into the RAG/ recipient. To
determine if autoreactive B cells targeting the same epidermal
proteins as Scurfy B cells are present in the B cell repertoire of
normal mice, we transferred CD4þ Scurfy T cells into either
RAG/ or nu/nu mice and bled the mice after 4 weeks. The
sera of the RAG/ recipients reconstituted with Scurfy
CD4þ T cells did not contain any autoantibodies (Figure 3b),
whereas the sera of the nu/nu recipients showed strong
reactivity with bands of a similar molecular weight as the
Scurfy serum (Figure 3b). Thus, autoreactive B cells recogniz-
ing epidermal targets are present in the normal B cell
repertoire and these B cells can be activated and receive help
from Scurfy T cells.
Identification of several keratins as targets for autoantibodies
in Scurfy mice
We resolved keratinocyte or whole-skin lysates using 2D
SDS-PAGE, stained with pooled Scurfy sera, and subjected
the spots reactive with Scurfy sera to protein identification
using peptide mass fingerprinting (PMF) after tryptic digestion
(Figure 4a). In both sets of experiments (keratinocyte and total
skin lysate), most of the proteins identified were keratins with
keratin 1, keratin 14, and keratin 2 yielding the highest scores
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Figure 3. Autoreactive B cells recognizing skin antigens are present in nu/nu
mice. (a) Total lymph node and spleen cells from a Scurfy mouse were
transferred into RAG/ recipients. At 4 weeks after transfer, mice were bled
and sera were analyzed individually by western blot analysis on keratinocyte
lysate as described earlier. The left panel shows staining with four Scurfy sera
as controls. (b) CD4þ T cells were purified from Scurfy lymph nodes and
transferred into either RAG/ or nu/nu recipients. The recipient mice were
bled 4 weeks after transfer, and the sera were analyzed individually as
described in (a). Sera from two mice of four in each group are shown.
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Figure 4. Scurfy autoantibodies target keratins. (a) Mouse ear lysate was
subjected to 2D gel electrophoresis, followed by Coomassie stain (left) or
western blot analysis using a pool of five Scurfy sera as primary antibody
(right). The numbers on the Coomassie-stained gel refer to spots identified by
PMF as shown in Table 1. (b) Total keratin was extracted from freshly isolated
keratinocytes from newborn mice, separated by SDS-PAGE, and analyzed by
western blot using either a monoclonal mouse anti-human keratin 14
antibody (LL001), which is cross-reactive to mouse keratin 14, or a Scurfy
serum as primary antibody.
www.jidonline.org 1393
EN Huter et al.
Autoantibodies Target Keratin 14
(Figure 4a; Table 1). As human keratins are a common source
of contamination, we also ran the resulting PMF against the
human database; human keratins gave drastically lower
scores than mouse keratins, strongly suggesting that the
keratins identified are of mouse origin (data not shown).
Keratins comprise intermediate filaments that are
expressed in epithelial cells, including keratinocytes (Lane
and McLean, 2004; Moll et al., 2008). Keratin 14 is expressed
mainly in the basal layer of the stratified epithelium in skin
and as keratinocytes differentiate on their way to the stratum
corneum, keratin 14 expression is reduced and finally lost
(McMillan et al., 2003). In contrast, other keratins, such as
keratin 10, are not found in basal keratinocytes, but their
expression is upregulated during differentiation (Ishida-
Yamamoto et al., 1992; Kartasova et al., 1993). We focused
on keratin 14 for further analysis, because keratin 14 might be
a dominant autoantigen not only important for skin disease,
but also for inflammation developing in Scurfy liver and lung
as both organs are affected in Scurfy mice and expression of
keratin 14 in liver and lung has been reported (Bisgaard et al.,
1994; Moll et al., 2008).
We extracted solubilized keratin filaments from mouse
keratinocytes using urea (Steinert et al., 1979). Keratin 14
could be readily identified in this keratin extract as an
B50 kDa band when the lysate was probed with a mouse
monoclonal anti-human keratin 14 antibody, which is known
to cross-react with murine keratin 14 (Figure 4b, left). When
Scurfy serum was used on the same keratin extract, a major
band of approximately the same molecular weight (B50 kDa)
was visible (Figure 4b, right), strongly suggesting that Scurfy
serum also recognizes keratin 14.
Scurfy autoantibodies recognize keratin 14
To conclusively show that keratin 14 is targeted by Scurfy
autoantibodies, we divided the mouse keratin 14 gene into
three fragments of equal size (B480bp each) and expressed
them in a bacterial system. The C-terminal (no. 3) and
middle fragments (no. 2) were expressed, but the N-terminal
fragment (no. 1) was not visualized on the Coomassie stain
(Figure 5a). The C-terminal fragment (no. 3) was reactive with a
rabbit polyclonal antibody against a synthetic peptide from the
C-terminal part of mouse keratin 14 (Figure 5b). Similarly,
Scurfy sera also recognized the C-terminal fragment (no. 3) of
keratin 14 (Figure 5c and d). Sera from nu/nu recipients that
had been reconstituted with Scurfy CD4þ T cells recognized
the C-terminal (no. 3) and middle fragment (no. 2), whereas
littermate controls did not recognize any fragment (Figure 5d).
CD4þ T cells from Scurfy mice recognize keratins
To show directly the presence of keratin-reactive T cells in
Scurfy mice, we isolated CD4þ T cells from skin-draining
lymph nodes of sick Scurfy mice and stimulated the cells
in vitro with the keratin extract used in Figure 4b. Scurfy
CD4þ T cells, but not CD4þ T cells from normal mice,
proliferated in response to this extract (Figure 6a). We then
sorted CD3þCD4þ T cells directly from inflamed skin and
stimulated them with anti-CD3/anti-CD28 and IL-2 to
increase cell numbers. After a resting phase in IL-2 alone,
the expanded Scurfy skin cells also proliferated when
challenged with the keratin extract (Figure 6b). When the
expanded cells were restimulated with phorbol 12-myristate
13-acetate and ionomycin and analyzed for intracellular
expression of cytokines, a high percentage produced Th2
Table 1. Results of protein identification
Spot number ID Score1 Number of peptides identified Coverage (%)
6 Albumin (Mus musculus) 1,262 29 48
9 Striated-muscle a-tropomyosin 296 7 27
11 Keratin 91 5 8
15 ATP synthase b-subunit 63 5 11
20 Keratin 15; 264 7 17
Vimentin (Mus musculus) 69 3 6
22 Keratin complex 1, acidic, gene 10 (Mus musculus) 1,175 25 36
23 Keratin 14 (Mus musculus) 413 14 24
24 Keratin 14 (Mus musculus) 143 8 16
25 Keratin 2 (Mus musculus) 392 10 15
Keratin 14 (Mus musculus) 99 6 13
26 Keratin 2 (Mus musculus) 68 3 5
28 Keratin 2 (Mus musculus) 152 6 9
29 Keratin complex 2, basic, gene 17 (Mus musculus) 135 6 10
Representative set of results of one protein identification of two with similar results is shown.
1Probability-based Mowse score; in general, ion scores of 54 or more indicated identity or intensive homology (Po0.05).
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cytokines, IL-4 and IL-5, which are characteristic of the atopic
dermatitis-like disease in Scurfy skin (Figure 6c).
IPEX patients harbor autoantibodies recognizing skin antigens
To determine if IPEX patients also develop autoantibodies
against skin antigens, we used sera from four IPEX patients.
We first analyzed the reactivity of the sera to murine
keratinocyte lysate and found reactive autoantibodies in the
serum of one patient (S390L) who had moderate eczema
(Figure 7a). We then used a human keratin lysate for western
blot analysis and found that the serum from the same patient
(S390L), which was reactive to the murine lysate (Figure 7b),
was strongly reactive with human keratin. Interestingly, the
sera from the other patients, but not from four normal
controls, also reacted with a protein ofB50 kDa, which may
correspond to keratin 14 (Figure 7b; data not shown). To
confirm that keratin 14 is contained in the human keratin
lysate, we performed western blot analysis with a mono-
clonal anti-human keratin 14 antibody (Figure 7b). The serum
of IPEX patient S390L was used to perform protein
identification using PMF. Human keratin lysate was subjected
to 2D gel electrophoresis followed by western blot analysis,
using serum of patient S390L as primary antibody. The spots
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Figure 5. Scurfy sera recognize epitopes in the C-terminal fragment of
keratin 14. (a) Three protein fragments of keratin 14 were expressed and
separated by SDS-PAGE, followed by Coomassie staining. (b) Fragments 1–3
were separated by SDS-PAGE, followed by western blot using a polyclonal
rabbit anti-mouse keratin 14 antibody (AF64) or the corresponding isotype
control as primary antibody. (c) The keratin 14 fragments were used either
undiluted or at a 1:10 or 1:100 dilution for western blot with Scurfy serum as
primary antibody. (d) The keratin 14 fragments were used for western blot as
in (b), but with Scurfy, WT littermate, or nu/nu recipient serum as primary
antibody. One representative experiment of at least three experiments with
similar results is shown.
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Figure 6. CD4þ T cells from Scurfy mice target keratins. (a) CD4þ T cells
were isolated from lymph nodes of Scurfy mice or normal controls and were
stimulated in vitro with antigen-presenting cell (APC) in the absence or
presence of different dilutions of keratin. Proliferation was measured after
4 days by 3H-thymidine uptake. Results are shown as mean±SD of triplicate
wells. One representative experiment of three is shown. (b) CD3þCD4þ
T cells were FACS-sorted from inflamed Scurfy ears, stimulated in vitro with
plate-bound anti-CD3/anti-CD28, rested in IL-2 for 7 days, and restimulated
in vitro with APC and keratin. Proliferation was measured as above. One
representative experiment of two is shown. (c) The cells were restimulated for
4 hours with phorbol 12-myristate 13-acetate (PMA)/ionomycin and stained
for intracellular cytokines.
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identified by PMF are shown in Table 2 and include keratin
14, keratin 10, and keratin 1 (Table 2). Keratin 14 and keratin
10 were found to yield the highest scores in the protein
identification with Scurfy sera, indicating that the same
antigenic targets are recognized. In the human protein
identification, one spot (no. 1.4) matched keratin 14 from
pan troglodytes. As there is a high degree of homology of
troglodyte keratin to human keratin 14 (94%), it is likely that
human keratin 14 is also a target. To conclusively demon-
strate that keratin 14 is recognized by human autoantibodies,
we analyzed the reactivity of the sera to the recombinant
murine keratin 14 fragments. The middle fragment (no. 2)
shows a high degree of homology with the human middle
part of keratin 14, and the C-terminal fragment (no. 3) is
100% homologous to the C-terminal portion of human
keratin 14. The N-terminal fragment was not expressed and
again served as negative control. Because serum of IPEX
patient S390L reacted strongly to bacterial proteins present in
the recombinant fragment solution, we subjected the sera
from IPEX patients to a preabsorption step on blotted pure
Escherichia coli protein extract before using the sera as primary
antibody for western blot analysis. The serum from IPEX patient
S390L recognized the C-terminal fragment of keratin 14,
whereas the other two sera tested did not show reactivity
(Figure 7c).
DISCUSSION
Scurfy mice develop severe autoimmune disease and die
between days 14 and 28 (Godfrey et al., 1991a, b). The skin is
affected in 100% of Scurfy mice, but the target structures for
the autoreactive T cells are not known. As an initial approach
to identify the targets in the skin, we characterized the
reactivity of autoantibodies that develop in Scurfy mice. We
found that keratins were the main proteins recognized in the
epidermis. The epitopes recognized by keratin-specific
antibodies are likely to be linear and not conformational as
the sera recognize both SDS-denatured and presumably
native keratin in cryosections. As cryosections were carried
out on normal ear skin, it is unlikely that they contain
denatured keratin.
Keratins represent a family of intermediate filaments
expressed in epithelia and typically form heteropolymeric
filaments by pairing type I and type II keratin molecules (Moll
et al., 2008). Keratin 14, which is usually expressed in the
basal layer of stratified epithelia, has a major role in
maintaining the stability of the skin (Troy and Turksen,
1999; Lane and McLean, 2004). Keratin 14 forms a
heterodimer with keratin 5 and mutations in the genes
encoding either one have been shown to account for a group
of blistering diseases in humans, termed epidermolysis
bullosa (Lane and McLean, 2004). In mice, the absence of
keratin 14 also leads to severe blistering and finally death
early in life (Troy and Turksen, 1999).
Given the functional importance of keratin 14 for
maintenance of skin function, it seems reasonable that Treg
cells might contribute to peripheral tolerance to this
autoantigen. Our analysis of the skin inflammation develop-
ing in Scurfy mice strongly suggests that keratin 14 may be a
target. First, the initial inflammatory infiltrate was localized in
the epidermis and in some areas the dermoepidermal border
was effaced (Figure 1a), consistent with a target antigen in the
basal layer of the epidermis. Second, the autoantibodies in
Scurfy sera recognize epidermal keratin 14 on western blot
analysis of total skin, of keratinocyte lysates, and by reactivity
with a fragment derived from recombinant keratin 14 (Figures
4 and 5). The autoantibodies themselves are not pathogenic,
as transfer of serum from a sick Scurfy mouse does not induce
disease in WT mice (data not shown). Scurfy mice also harbor
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Figure 7. Autoantibodies in sera from IPEX patients recognize skin antigens.
(a) Murine keratinocyte lysate was separated by SDS-PAGE, followed by
western blot using sera of different immunodysregulation, polyendocrinopathy,
enteropathy, X-linked (IPEX) patients or of a healthy donor. Serum from
a Scurfy mouse served as positive control. One experiment of two with
similar results is shown. (b) Human keratin lysate was separated by
SDS-PAGE, followed by western blot using sera of different IPEX patients.
The two right lanes show staining with either mouse anti-human keratin 14
antibody (LL001) or isotype control. One experiment of four with similar results
is shown. (c) After preabsorption of the diluted IPEX sera on Escherichia coli
proteins blotted onto polyvinylidene difluoride membranes, the sera were
used separately for western blot analysis on the different fragments of murine
keratin 14.
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skin-reactive T cells, as CD4þ T cells from both skin and
draining lymph nodes proliferated specifically when stimu-
lated with the bulk preparation of keratins. Further studies
will be needed to define the fine specificity of CD4þ T cells
present in Scurfy mice.
In human autoimmune skin diseases keratins might also be
potential autoantigenic targets. Using a similar approach as
we did, one study previously identified keratin 10-specific
antibodies in sera of psoriasis patients by protein identifica-
tion (El-Rachkidy et al., 2008). Another recent study reported
anti-keratin autoantibodies in patients with rheumatoid
arthritis (Quismorio et al., 2008). In this study, we identified
different keratins as antigenic targets for the autoantibodies in
sera from IPEX patients. Two of the IPEX patients tested
had skin disease and the serum from one patient, who had
moderate eczema (S390L), showed strong reactivity against
skin antigens, including keratin 14. Thus, our identification of
keratin 14 as an antigenic target should facilitate the analysis
of the specificity of autoreactive T cells in human skin
diseases and thereby provide potential impact on future
therapeutic strategies.
MATERIALS AND METHODS
Mice
Female heterozygous B6.Cg-Foxp3sf/J (Scurfy) mice were purchased
from Jackson Laboratories (Bar Harbour, ME) and bred to C57BL/6
WT male mice to generate hemizygous male B6 (Cg-Foxp3sf/Y
(Scurfy) offspring); C57BL/6 WT male littermates were used as
controls. C57BL/6 RAG/ mice and C57BL/6 nu/nu mice were
purchased from Taconic (Rockville, MD). All mice were held under
specific pathogen-free conditions and cared for in accordance with
guidelines approved by the NIAID Animal Care and Use Committee.
Antibodies and reagents
Monoclonal anti-keratin 14 antibody (clone LL001) and the
corresponding isotype control (mouse IgG2a) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The rabbit poly-
clonal antikeratin 14 antibody (AF64) was purchased from Abcam
(Cambridge, MA).
Histology
Ears were fixed in 4% neutral buffered formalin. Fixed tissues were
embedded in paraffin and stained with hematoxylin and eosin by
American Histolabs (Gaithersburg, MD).
Immunohistochemistry
Back skin of C57BL/6 RAG/ mice was snap-frozen in OCT com-
pound embedding medium (Tissue-Tek, Sakura Finetek, Torrance,
CA). Sections were cut on a cryostat, air-dried, fixed in ice-cold
acetone, and stored at 20 1C until further use. The sections were
rehydrated two times, and blocked with 10% goat serum in 5% skim
milk powder in phosphate-buffered saline (PBS) at room temperature
(RT). Slides were incubated with Scurfy or WT serum at a 1:70
dilution for 1 hour at RT, washed three times for 5minutes with PBS
and incubated with goat anti-mouse IgG Alexa Fluor 488 (Invitrogen,
Carlsbad, CA) 1:500 in PBS for 1 hour at RT in the dark. After
washing three times for 5minutes with PBS, slides were mounted
with ProLong Gold antifade reagent with DAPI counterstain
(Invitrogen).
Keratin isolation
Keratinocytes were isolated from newborn C57BL/6 mice as
previously described (Lichti et al., 2008). The keratin intermediate
filaments were isolated using 8M urea as previously described
(Steinert et al., 1979). Keratin solution from human epidermis was
purchased from Sigma-Aldrich (St Louis, MO).
Western blot
Ears from C57BL/6 RAG/ mice or freshly isolated keratinocytes
from 1-day-old C57BL/6 mice were homogenized on ice in lysis
buffer containing 5mM Tris (pH 8.0), 150mM NaCl 1% NP-40, and
protease inhibitor cocktail (Roche, Indianapolis, IN). The lysates
were spun for 10minutes at 4 1C at 12,000 r.p.m. in an Eppendorf
table-top centrifuge and supernatants were stored at 80 1C.
Samples were diluted in NuPAGE 4 sample buffer (Invitrogen)
supplemented with 5% b-mercaptoethanol, boiled for 5minutes at
95 1C, put on ice for 1minute, spun down, separated by 10 or 12%
SDS-PAGE gels, and blotted onto Hybond-ECL nitrocellulose
membranes (Amersham, Piscataway, NJ). The membrane was
Table 2. Results of protein identification
Spot number ID Score1 Number of peptides identified Coverage (%)
1.3 Keratin 10 (Homo sapiens) 285 8 13
Keratin 9 (Homo sapiens) 180
Keratin 1 (Homo sapiens) 108
1.4 Keratin, type I cytoskeletal 14 (cytokeratin-14) (Pan troglodytes) 316 13 9
Keratin 9 (Homo sapiens) 300
Keratin 10 (Homo sapiens) 280
1.5 Keratin 1 (Homo sapiens) 265 7 10
Keratin, type I cytoskeletal 14 (cytokeratin-14) (Pan troglodytes) 245
Keratin 9 (Homo sapiens) 217
1Probability-based Mowse score; in general, ion scores of 54 or more indicated identity or intensive homology (Po0.05).
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blocked (5% skim milk in PBS 0.1% Tween 20) for 1 hour at RT with
shaking, followed by incubation in block with either Scurfy
or WT serum or IPEX patient or healthy control serum overnight at
4 1C with shaking. After washing five times in PBS 0.1% Tween 20,
the membrane was incubated with horseradish-peroxidase-
conjugated sheep anti-mouse IgG (dilution 1:10,000; Amersham),
horseradish-peroxidase-conjugated sheep anti-rabbit IgG (dilution
1:10,000; Amersham), or horseradish-peroxidase-conjugated goat
anti-human IgG(g) (dilution 1:5,000; Invitrogen) for 1 hour at RT,
washed five times in PBS 0.1% Tween 20, and developed with
enhanced chemiluminescence reagent (Pierce, Rockford, IL) and
autoradiography (Amersham).
Protein identification by mass spectrometry
Keratinocyte or total skin lysates were separated on 2D SDS-PAGE
gels. Protein identification of 2D gel-separated proteins was
performed on reduced and alkylated, trypsin-digested samples
prepared by standard mass spectrometry protocols. Tryptic digests
were analyzed by coupling the Nanomate (Advion BioSciences,
Ithaca, NY), an automated chip-based nanoelectrospray interface
source, to a quadrupole time-of-flight mass spectrometer, QStar
XL MS/MS System (Applied Biosystems/Sciex, Foster City, CA).
Computer-controlled data-dependent automated switching to
MS/MS provided peptide sequence information. AnalystQS soft-
ware (Applied Biosystems/Sciex) was used for data acquisition. Data
processing and databank searching were performed with Mascot
software (Matrix Science, Boston, MA). The NCBInr protein database
from The National Center for Biotechnology Information, NLM/NIH
was used for the search analysis.
Statistics
Ion score was 10 log(P), where P is the probability that the
observed match is a random event. Individual ions scores X54
indicate identity or extensive homology (Po0.05). Protein scores are
derived from ions scores as a nonprobabilistic basis for ranking
protein hits.
Keratin 14 expression
A vector with the complete mouse keratin 14 cDNA was purchased
from OriGene (Austin, TX). The following primer pairs were used
to amplify three B480bp cDNA fragments encoding for the
N-terminal, middle, and C-terminal parts of keratin 14: primer 1
(forward), TGCACGGCTAGCGCCACCTGCAGCCGCCAGTTCACC
TCCTCCAGC; primer 2 (reverse), TGCACGAAGCTTTTAGTCTTTGA
TCTCAGTGGGCCGCTGCCTCTG; primer 3 (forward), TGCACGGC
TAGCTACCAGAGGCAGCGGCCCACTGAGATCAAAGAC; primer
4 (reverse), TGCACGAAGCTTTTACTTGCCGCTCTGCACCAGCTC
GCTGTTGGT; primer 5 (forward), TGCACGGCTAGCGCCACCAAC
AGCGAGCTGGTGCAGAGCGGCAAG; primer 6 (reverse), TGCA
CGAAGCTTTTAGTTCTTGGTGCGCAGGACCTGCTCGTGGGT.
The PCR fragments were cloned into the pET-21b vector
(Novagen, Darmstadt, Germany) and used to transform BL21
(DE3)-competent cells (Novagen). Bacterial expression was induced
by addition of 1M IPTG to bacterial cultures. After 2.5 hours, bacteria
were pelleted and lysed with lysis buffer (BUGBuster Protein
Extraction ReagentþBenzolaseþ Lysozyme; all from Novagen).
After additional centrifugation, the pellet containing insoluble
inclusion bodies was washed twice in TE and stored at 20 1C until
further use.
Cell isolation and transfer
CD4þ T cells were isolated from lymph nodes through the positive-
select program on AutoMACS (Miltenyi, Auburn, CA). The cells were
washed, resuspended in PBS, and injected i.v. into either C57BL/6
RAG/ or C57BL/6 nu/nu recipients. Total lymph node and spleen
cells from 10- to 14-day-old Scurfy mice were pooled, washed,
resuspended in PBS, and injected i.v. into C57BL/6 RAG/
recipients.
T-cell proliferation assays
T cells were magnetically sorted with CD4 microbeads (Miltenyi)
or were FACS-sorted. T cells were stimulated with irradiated
(3,000 rad) T-depleted WT splenocytes in the absence or presence
of the indicated dilutions of keratin extract. Staining for intracellular
cytokines was performed as previously described (Stummvoll
et al., 2008).
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